Complete UK Comparison: Wegovy vs Mounjaro
Wegovy vs Mounjaro UK: Understanding the Key Mechanisms
The primary difference between Wegovy and Mounjaro lies in their mechanisms of action. Wegovy contains semaglutide, which works as a GLP-1 receptor agonist, mimicking the natural hormone that signals fullness to your brain. Mounjaro contains tirzepatide, a dual agonist that targets both GIP and GLP-1 receptors, potentially offering a different approach to appetite regulation. Both prescription-only medicines are designed to reduce appetite and promote feelings of satiety when used alongside lifestyle modifications. Understanding these mechanistic differences is crucial when comparing Wegovy vs Mounjaro for UK patients.
Clinical evidence suggests both treatments can be effective for weight management, though they achieve results through different pathways. Wegovy's established GLP-1 mechanism has been extensively studied in the STEP trial programme, whilst Mounjaro's dual-hormone approach represents a newer therapeutic strategy. When considering Wegovy vs Mounjaro UK options, your prescriber can help determine which mechanism may be most suitable for your individual circumstances. Both treatments are available through EverydayMeds with full clinical support throughout your weight management journey.
Wegovy vs Mounjaro UK Pricing: Complete Cost Comparison
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro, making this comparison straightforward for UK patients. Wegovy starts at £79.99 for the 0.25mg starter dose (with code FIRST40 for new customers), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Returning customers can use code DOSE25 for continued savings throughout their treatment journey. The Intro Duo bundle (0.25mg and 0.5mg) costs £169.99, providing convenient starter supply for the first two months.
When evaluating Wegovy vs Mounjaro UK pricing, consider that both treatments require dose escalation protocols, though with different schedules and final maintenance doses. EverydayMeds' bundle options provide convenience through Reliable Supply and reduced ordering frequency, with the Ultimate Stability Trio offering three months of 2.4mg maintenance for £649.99. Both treatments include the same high-quality service: clinical assessment, prescriber review, and next-day cold-chain delivery. The choice between Wegovy vs Mounjaro UK often comes down to clinical suitability rather than cost, as both represent significant investments in long-term weight management.
Clinical Evidence for Wegovy vs Mounjaro UK Patients
Wegovy's clinical evidence comes primarily from the STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial additionally showed a 20% reduction in major cardiovascular events, providing evidence beyond weight management. When comparing Wegovy vs Mounjaro UK evidence, it's important to note that trials used different designs and patient populations.
Both treatments have shown efficacy in clinical trials when used alongside reduced-calorie diets and increased physical activity, though direct head-to-head comparisons are limited. The evidence supports both options for appropriate patients, making the choice between Wegovy vs Mounjaro UK dependent on individual clinical factors rather than superiority of one over the other. Your EverydayMeds prescriber can review your specific circumstances to help determine which treatment may be most suitable.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy works as a GLP-1 receptor agonist, mimicking a natural hormone that regulates appetite and food intake. When you eat, GLP-1 is naturally released, signalling fullness to your brain and slowing gastric emptying. Wegovy enhances these natural processes, helping you feel satisfied with smaller portions and reducing food cravings between meals. The treatment specifically targets brain appetite centres, which may help explain why patients often report reduced interest in food rather than just feeling physically full. This mechanism requires time to establish, which is why Wegovy uses a gradual dose escalation protocol over 16 weeks. Understanding this mechanism is essential when considering Wegovy vs Mounjaro UK options, as each treatment offers a different approach to appetite regulation.
Wegovy vs Mounjaro UK: Complete Ordering Process
EverydayMeds streamlines access to both Wegovy and Mounjaro through a comprehensive three-step process designed for UK patients. The journey begins with a detailed three-minute online clinical assessment covering your medical history, current medications, and weight management goals. Your assessment is then reviewed by qualified prescribers, typically within three working days (or 24 hours with express service), ensuring appropriate clinical oversight for these prescription-only medicines. Once approved, your treatment is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The process includes ongoing support from the EverydayMeds clinical team (GPhC #9012878), ensuring you receive expert guidance whether choosing Wegovy or Mounjaro. This comprehensive approach means you can access either treatment with confidence, knowing that clinical safety and convenience are prioritised throughout your weight management journey.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
Storage requirements represent a practical difference when comparing Wegovy vs Mounjaro UK options. Wegovy offers superior temperature flexibility, maintaining stability for up to six weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater convenience for travel or lifestyle flexibility. Wegovy uses Novo Nordisk's FlexTouch pen system, which many patients find intuitive for weekly self-injection. The dose escalation schedule for Wegovy spans 16 weeks, moving systematically from 0.25mg to the 2.4mg maintenance dose, allowing your body to adapt gradually to the treatment. These practical considerations can influence treatment preference alongside clinical factors when evaluating Wegovy vs Mounjaro UK options.
Wegovy vs Mounjaro UK: Making the Right Choice
The decision between Wegovy and Mounjaro for UK patients involves multiple factors beyond simple efficacy comparisons. Wegovy's established GLP-1 mechanism offers extensive clinical evidence and proven cardiovascular benefits, whilst Mounjaro's dual-hormone approach represents a newer therapeutic strategy that may suit different patient profiles. Individual factors such as treatment history, comorbidities, and lifestyle considerations all influence which option may be most appropriate. Your response to previous treatments, injection frequency preferences, and storage convenience requirements can all factor into the decision-making process.
EverydayMeds' advantage lies in offering both treatments through the same high-quality service, removing the need to choose between different pharmacies when comparing Wegovy vs Mounjaro UK options. Our clinical team can provide detailed guidance on both treatments, helping you understand which mechanism may align best with your weight management goals. Rather than declaring one superior to the other, we focus on matching the right treatment to the right patient, ensuring optimal outcomes regardless of which option you choose.
Start Your Wegovy vs Mounjaro UK Comparison Today
Ready to explore either Wegovy or Mounjaro through EverydayMeds? Begin with our three-minute clinical assessment at https://everydaymeds.co.uk/collections/weight-loss, where you can indicate your treatment preference or request guidance from our prescribers. New customers can use code FIRST40 for optimal pricing, whilst returning customers benefit from code DOSE25 for continued value. Both treatments require clinical assessment and ongoing prescriber oversight, ensuring your safety throughout treatment. Our GPhC-registered pharmacy (#9012878) maintains the highest standards for both Wegovy and Mounjaro supply, with temperature-controlled delivery and comprehensive patient support. Whether you choose Wegovy's proven GLP-1 approach or Mounjaro's dual-hormone mechanism, EverydayMeds provides the expertise and convenience you need for successful weight management alongside a reduced-calorie diet and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
